{
    "2021-05-13": [
        [
            {
                "time": "",
                "original_text": "JPMorgan Chase & Co.增持康龙化成股份约7.72万股",
                "features": {
                    "keywords": [
                        "JPMorgan Chase",
                        "康龙化成",
                        "增持",
                        "7.72万股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【权益变动】康龙化成(03759.HK)获摩根大通增持7.7166万股",
                "features": {
                    "keywords": [
                        "摩根大通",
                        "康龙化成",
                        "增持",
                        "7.7166万股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康龙化成现4笔大宗交易 共成交8,393.50万元",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "大宗交易",
                        "8,393.50万元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业CXO系列报告之四：一季报表现优异 投融资数据靓丽 持续看好CXO赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "一季报",
                        "投融资数据",
                        "持续看好"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2023-05-12",
                "original_text": "康龙化成5月12日现4笔大宗交易",
                "features": {
                    "keywords": [
                        "康龙化成",
                        "大宗交易",
                        "5月12日"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}